Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
1.530
+0.020 (1.32%)
Feb 11, 2026, 3:33 PM EST - Market open
Akebia Therapeutics Market Cap
Akebia Therapeutics has a market cap or net worth of $406.01 million as of February 11, 2026. Its market cap has decreased by -21.82% in one year.
Market Cap
406.01M
Enterprise Value
439.90M
1-Year Change
-21.82%
Ranking
Category
Stock Price
$1.53
Market Cap Chart
Since March 20, 2014, Akebia Therapeutics's market cap has decreased from $488.10M to $406.01M, a decrease of -16.82%. That is a compound annual growth rate of -1.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 398.00M | -6.84% |
| Dec 31, 2025 | 427.20M | 3.06% |
| Dec 31, 2024 | 414.50M | 77.44% |
| Dec 29, 2023 | 233.60M | 120.17% |
| Dec 30, 2022 | 106.10M | -73.17% |
| Dec 31, 2021 | 395.40M | -2.30% |
| Dec 31, 2020 | 404.70M | -46.16% |
| Dec 31, 2019 | 751.70M | 138.26% |
| Dec 31, 2018 | 315.50M | -55.11% |
| Dec 29, 2017 | 702.90M | 76.17% |
| Dec 30, 2016 | 399.00M | 0.81% |
| Dec 31, 2015 | 395.80M | 67.15% |
| Dec 31, 2014 | 236.80M | -51.49% |
| Mar 20, 2014 | 488.10M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Emergent BioSolutions | 579.82M |
| Organogenesis Holdings | 487.34M |
| SIGA Technologies | 479.08M |
| Kamada | 477.13M |
| Aquestive Therapeutics | 470.93M |
| Canopy Growth | 417.56M |
| Eton Pharmaceuticals | 407.89M |
| Evolus | 288.45M |